首页

Zhaoke Ophthalmology’s Myopia Drug, Atropine Sulfate Eye Drops, Accepted for Registration Evaluation in Australia

2026-01-13

Zhaoke Ophthalmology Partners with TSH Biopharm to Bring Innovative Presbyopia Therapy BRIMOCHOLTM PF to Taiwan Region

2025-12-08

485

Zhaoke Ophthalmology Donates HK$200,000 to the “Support Fund for Wang Fuk Court in Tai Po” to Assist with the Post-Tragedy Rescue Operations

2025-12-01

378

Zhaoke Ophthalmology Obtains IND Approval for its Second Back-of-Eye Drug PAN-90806 and Marketing Authorization for Epinastine HCl Eye Drop

2025-11-24

698

Zhaoke Ophthalmology Secures Second Partnership with PT Ferron for Commercialization in Indonesia for BRIMOCHOL™ PF

2025-11-06

1433

首页 1 2 3 4 5 尾页

Guangzhou Headquarters

Tel: 020-39062828

E-mail: info@zkoph.com

Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou

Hong Kong Headquarters

Tel: (852)23145100

E-mail: info@zkoph.com

Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong

Wechat

Guangzhou Headquarters

Tel: 020-39062888

E-mail: info@zkoph.com

Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou

Hong Kong Headquarters

Tel: (852)23145100

E-mail: info@zkoph.com

Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong

Wechat